High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma

By Davidson Ben   Goldberg Iris   Gotlieb Walter   Kopolovic Juri   Ben-Baruch Gilad   Nesland Jahn   Berner Aasmund   Bryne Magne   Reich Reuven  

Clinical and Experimental Metastasis, Vol. 17, Iss. 10, 1999-12 ,pp. : 799-808

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of MMP2, MMP9, TIMP1, TIMP2, NGAL and MMP9/NGAL complex in urine and sera from patients with bladder cancer

By      

Oncology Letters, Vol. 10, Iss. 4, 2015-01 ,pp. : 2527-2532

Spandidos Publications

Access to resources Recommend Favorite

Expression of MMP-2, -7, -9, MT1-MMP and TIMP-1 and -2 has no prognostic relevance in patients with advanced epithelial ovarian cancer

By            

Oncology Reports, Vol. 27, Iss. 4, 2012-01 ,pp. : 1049-1057

Spandidos Publications

Access to resources Recommend Favorite

Norcantharidin enhances TIMP2 antivasculogenic mimicry activity for human gallbladder cancers through downregulating MMP2 and MT1MMP

By  

International Journal of Oncology, Vol. 46, Iss. 2, 2015-01 ,pp. : 627-640

Spandidos Publications

Access to resources Recommend Favorite

Expressions and clinical significances of MMP-2 and TIMP-2 mRNA in bladder transitional cell carcinomas

By Wang Yunyan   Meng Junsong   Zhuang Haijun   Hou Jianquan   Wen Duangai  

The Chinese-German Journal of Clinical Oncology, Vol. 10, Iss. 5, 2011-05 ,pp. : 278-281

Springer Publishing Company

Access to resources Recommend Favorite